Stem Cell Network   Report issue

Foundation Phase 1 Phase 2
Founded: Ottawa Canada (2001)

Organization Overview

First Clinical Trial
2018
NCT03369275
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Stem Cell Network | Stem Cell Network (SCN)